Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb;55(3):366-367.
doi: 10.1111/apt.16759.

Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' reply

Affiliations
Editorial

Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' reply

Jeremy S Nayagam et al. Aliment Pharmacol Ther. 2022 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Bolio R, Srivastava A. Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Aliment Pharmacol Ther. 2022;55:364-365.
    1. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374(9701):1617-1625.
    1. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141(5):1621-1628.
    1. Jensen MD, Jepsen P, Vilstrup H, et al. Increased cancer risk in autoimmune hepatitis: a Danish Nationwide Cohort Study. Am J Gastroenterol. 2021. https://doi.org/10.14309/ajg.0000000000001525 [Online ahead of print].
    1. Nayagam JS, Heneghan MA, Samyn M, Joshi D. Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver disease. Aliment Pharmacol Ther. 2021; https://doi.org/10.1111/apt.16708.

MeSH terms